How many clinical trials are studying Pentoxifylline?

4 recruiting trials in our tracked data involve Pentoxifylline.

What conditions is Pentoxifylline being studied for?

In our tracked recruiting trials, Pentoxifylline is being studied in trials for Eisenmenger Syndrome, Hypertension, Inflammatory Bowel Diseases.

Pentoxifylline: clinical trials recruiting now

Q: Is Pentoxifylline FDA-approved?

Yes. According to the FDA drug label available through openFDA, Pentoxifylline is an FDA-approved drug.

Recruiting trials

Conditions studied

US states with sites

Countries

FDA drug label

FDA-approved: Yes. Pentoxifylline appears in the FDA drug-label database. Marketed as PENTOXIFYLLINE.
Drug class: Blood Viscosity Reducer (FDA established pharmacologic class)

FDA-approved use

Pentoxifylline extended-release tablets are indicated for the treatment of patients with intermittent claudication on the basis of chronic occlusive arterial disease of the limbs. Pentoxifylline can improve function and symptoms but is not intended to replace more definitive therapy, such as surgical bypass, or removal of arterial obstructions when treating peripheral vascular disease.

FDA label via openFDA

Phase breakdown

Phase 2 3 Not applicable 1

Conditions being studied

Condition	Trials
Eisenmenger Syndrome	1
Hypertension	1
Inflammatory Bowel Diseases	1
Lung cancer	1
Non-Small Cell Lung Cancer	1
Radiation Induced Lung Injury (RILI)	1
Rheumatoid Arthritis	1
Ulcerative colitis	1

Recruiting trials involving Pentoxifylline

Pentoxifylline as Anti-Inflammatory in Patients With Rheumatoid Arthritis
NCT06998628 · Phase: Phase 2 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 1 location
Pentoxifylline as an Adjunct Therapy for Patients With Eisenmenger Syndrome
NCT05611268 · Phase: Not applicable (e.g. observational or device study) · Ages: 10 Years to 80 Years · Sex: All (male and female) · 1 location
Pentoxifylline in Patients With Ulcerative Colitis
NCT07349472 · Phase: Phase 2 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 1 location
Pneumonitis Prevention Protocol Using Pentoxifylline and α-tocopherol In Stage III Non-Small Cell Lung Cancer Patients Undergoing Chemoradiation
NCT06634056 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location

Common questions

Is Pentoxifylline FDA-approved?

Yes, marketed as PENTOXIFYLLINE.

How many recruiting trials involve Pentoxifylline?

4 recruiting trials across 8 conditions.

Is this list of trials complete?

No. For the full record, search ClinicalTrials.gov.